Article
Lithium reverses behavioral and axonal transport-related changes associated with ANK3 bipolar disorder gene disruption.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 1 Mar 2017
Gottschalk Michael G, Leussis Melanie P, Ruland Tillmann, Gjeluci Klaudio, Petryshen Tracey L, Bahn Sabine
Abstract excerpt
Ankyrin 3 (ANK3) has been implicated as a genetic risk factor for bipolar disorder (BD), however the resulting pathophysiological and treatment implications remain elusive. In a preclinical systems biological approach, we aimed to characterize the behavioral and proteomic effects of Ank3 haploinsufficiency and chronic mood-stabilizer treatment in mice. Psychiatric-related behavior was evaluated with the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
